ArticleFrontiers in immunology2026

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study.

Huilin Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.